More evidence hydroxychloroquine is ineffective, harmful in COVID-19
May 27, 2020
New observational data show that hydroxychloroquine it is not only without benefit for COVID-19 but also increases death and arrhythmias.
Double Masking and Decontamination: A Doctor’s COVID-19 Routine
April 22, 2020
Gary S. Ferenchick, MD, MS, a professor of medicine at Michigan State University, interviewed his daughter, Hannah R.B. Ferenchick, MD, an emergency and critical care physician, about her experiences taking care of COVID-19 patients.See their earlier conversation about "silent hypoxemia" and other clinical observations of COVID-19 patients.
‘Silent Hypoxemia’ and Other Curious Clinical Observations in COVID-19
April 16, 2020
Gary S. Ferenchick, MD, MS, a professor of medicine at Michigan State University, interviewed his daughter, Hannah R.B. Ferenchick, MD, an emergency and critical care physician working on the frontline in a busy Detroit hospital, about some of the unusual clinical features of patients with suspected or confirmed COVID-19.
Critical care and COVID-19: Dr. Matt Aldrich
March 30, 2020
Matt Aldrich, MD, medical director of critical care at UCSF Health in San Francisco, speaks about critical care issues in COVID-19.
Treatment options for COVID-19: Dr. Annie Luetkemeyer
March 25, 2020
Dr. Annie Luetkemeyer, professor of infectious diseases at UCSF, spoke with Dr. Robert Wachter, chair of the UCSF Department of Medcine, about the evidence behind potential treatments for COVID-19.
Managing the COVID-19 isolation floor at UCSF Medical Center
March 23, 2020
Armond Esmaili, MD, a hospitalist and assistant professor of medicine at UCSF, leads the Respiratory Isolation Unit at UCSF Medical Center, where the institution's COVID-19 and rule-out COVID-19 patients are being cohorted.
Novel cardiac troponin protocol rapidly rules out MI
October 3, 2019
PARIS – Three-quarters of patients who presented with suspected acute coronary syndrome were safely discharged from ED without hospital admission.
Beta-blockers effective, safe for HFrEF with renal dysfunction
September 23, 2019
PARIS – Meta-analysis of more than 17,000 heart failure patients showed efficacy and safety of beta-blockers in moderate renal dysfunction.
Highlights from the ‘Updates in ACS’ session (VIDEO)
April 12, 2019
HM19 attendees discuss the key lessons from the Updates in Acute Coronary Syndrome session.
HM19: Lessons from the Update in Hospital Medicine session
April 5, 2019
Dr. Amith Skandhan and Dr. Raman Palabindala discuss more of their favorite lessons from HM19.